Two in five heart failure and CKD patients show elevated cardiovascular inflammation

New research from Dubai reveals that 40% of patients with heart failure and chronic kidney disease (CKD) exhibit elevated cardiovascular inflammation, a significant finding that underscores the persistent risk factors associated with these conditions. This study, part of the POSEIDON real-world analysis, highlights the need for more comprehensive monitoring and targeted therapies to manage CV inflammation, which can lead to severe complications. Understanding these persistent risks is crucial for improving patient outcomes and reducing the overall burden of cardiovascular diseases.